bromocriptine has been researched along with Neuroleptic Malignant Syndrome in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (32.17) | 18.7374 |
1990's | 41 (35.65) | 18.2507 |
2000's | 26 (22.61) | 29.6817 |
2010's | 6 (5.22) | 24.3611 |
2020's | 5 (4.35) | 2.80 |
Authors | Studies |
---|---|
Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R | 1 |
Irfan, N; Khalid, Z; Zaidi, S | 1 |
Angulo, NY; Castaño, PA; Gómez, CC; Quintero, S | 1 |
Elyasi, F; Heydari, F; Sadati, S | 1 |
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P | 1 |
Bc, M; Chatterjee, SS; Das, S; Kartha, A; Purushothaman, ST; Rajan, V | 1 |
Barahona-Corrêa, JB; Neves, A; Oliveira-Maia, AJ; Velosa, A | 1 |
Fraile, S; García, B; Hidalgo, FJ; Lopez, E | 1 |
Ikushima, G; Kameda, K; Koinuma, M; Shoko, T; Takahashi, K; Watarai, K | 1 |
Graudins, A; Green, D; Morris, E | 1 |
Gillman, K | 1 |
Gillman, PK | 1 |
Onder, E; Tural, U | 1 |
Kuhlmann, A; Müller, T; Reimer, J | 1 |
Reingardiene, D | 1 |
Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N | 1 |
Alkin, T; Demopulos, CM; Ozerdem, A; Sagduyu, K; Yildiz, A | 1 |
Nishijima, K | 1 |
Anand, JS; Chodorowski, Z; Rutkowski, P | 1 |
Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T | 1 |
Bozoklu, A; Dener, C; Koçak, OM; Sen, M; Tunca, A | 1 |
Andrade, CR; Mendhekar, DN | 1 |
Amaro, S; Gaig, C; Gómez-Choco, MJ; Martí, MJ; Tolosa, E | 1 |
Nagamine, M; Nomura, S; Sakurai, Y; Sanga, M; Takahashi, R; Yoshino, A | 1 |
Jiloha, RC; Mendhekar, DN | 1 |
Collumbien, EC; Smidt, MH | 1 |
Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M | 1 |
Akan, M; Akdede, B; Akvardar, Y; Kosehasanogullari, SG; Tunca, Z | 1 |
Caroff, SN; Keck, PE; Strawn, JR | 1 |
Santens, P; Vancaester, E | 1 |
Furuno, T; Kawanishi, C; Kishida, I | 1 |
Joshi, AS; Khobragade, AK; Patel, AL; Sahastrabuddhe, GS; Shaikh, WA; Soni, HG | 1 |
Archambeaud-Mouveroux, F; Dallet, A; Papapietro, P; Parini, M; Vincent, D | 1 |
Rónai, L; Wagner, G | 1 |
Marken, PA; Schneiderhan, ME | 1 |
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK | 1 |
Minnema, AM; Reddig, S; Tandon, R | 1 |
Becker, BN; Ismail, N | 1 |
Kornhuber, J; Weller, M | 1 |
Byrd, C | 1 |
Cervero Jiménez, M; Fernández Ballesteros, A; Marco Martínez, J; Martín Joven, A | 1 |
Aibiki, M; Chikano, S; Ogli, K; Onaka, A; Shirakawa, Y; Yokono, S | 1 |
Borzotta, AP; Galloway, GQ; Hirst, R | 1 |
Alted Lopez, E; Ambros Checa, A; Caballero Cubedo, R; Perez-Vela, JL; Sanchez Casado, M; Sanchez-Izquierdo Riera, JA | 1 |
Ganelin, L; Lichtenberg, PS; Marcus, EL; Munter, RG | 1 |
Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B | 1 |
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A | 1 |
Freedman, MD | 1 |
Batalla, A; Cruz, JM; Cutrin, C; Gómez, XA; Pato, M | 1 |
Deppe, S; Epperly, N; Friedman, B; Law, E; Orlet, H; Still, J | 1 |
Sunohara, N | 1 |
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H | 1 |
Barron, TF; Dayner, J; Trasmonte, J | 1 |
Koyama, T; Kusumi, I | 1 |
Geurts, M; Maloteaux, JM; Noël, F | 1 |
Privette, T; Stanfield, SC | 1 |
Chew, EL; Ong, KC; Ong, YY | 1 |
Susman, VL | 1 |
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U | 1 |
Lee, MK; Loh, TG; Ong, SB; Tan, CT | 1 |
Chiang, WK; Herschman, Z | 1 |
Chaudhry, HR; Javed, A | 1 |
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F | 1 |
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY | 1 |
Retamal, P | 1 |
Kanchanapongkul, J | 1 |
Patkar, AA; Shah, LP | 1 |
Mazurek, MF; Rosebush, PI; Stewart, T | 1 |
Disch, M; Manheimer, E; Nierenberg, D; Patterson, J; Ross, J; Silvestri, G; Summerhill, E | 1 |
Misra, A | 1 |
Epperly, TD; Leo, KU; McGlaughlin, VG | 1 |
Mazurek, MF; Rosebush, PI | 1 |
Colardyn, F; De Reuck, J; Van Aken, J; Van Landegem, W | 1 |
Keck, PE; McElroy, SL; Pope, HG; Seeler, DC | 1 |
Baca, L; Martinelli, L | 1 |
Delerue, O; Destée, A | 1 |
Chinyanga, HM; Constantinou, E; Haisma, HJ | 1 |
Björk, E; Hallberg, A; Martinussen, HJ; Trost, AC | 1 |
Bhaskaran, R; Kunju, PA; Nair, KR | 1 |
Hippius, H; Spiess-Kiefer, C | 1 |
Adityanjee, PD; Chawla, HM | 1 |
Avasthi, A; Giridhar, C; Singh, SP | 1 |
Lazarus, A | 2 |
Jeste, DV; Sewell, DD | 1 |
Goldwasser, HD; Hooper, JF; Spears, NM | 1 |
Mueller, PS | 1 |
Levenson, JL | 1 |
Keltner, NL; McIntyre, CW | 1 |
Gorelick, PB; Greenberg, MS | 1 |
Munitz, H; Shalev, A | 1 |
Dick, P; Schulz, P | 1 |
Bentsen, BS; Gillette, GM; Haggerty, JJ | 1 |
Donovan, K; Fahn, S; Gross, J; Sczesni, B; Truong, DD; van Bakel, A; Wiley, MK | 1 |
Olmsted, TR | 1 |
Goldwasser, HD; Hooper, JF | 1 |
Guerrero, RM; Shifrar, KA | 1 |
Andrade, NN | 1 |
Herjanic, M; Schvehla, TJ | 1 |
Arora, A; Kapoor, SK; Malhotra, OP; Misra, A | 1 |
Colvin, S; Lieberman, A; Pasternack, P | 1 |
Rampertaap, MP | 1 |
Abbott, RJ; Loizou, LA | 1 |
Arana, GW; Cahill, C | 1 |
Janati, A; Webb, RT | 1 |
Dhib-Jalbut, S; Hesselbrock, R; Means, ED; Mouradian, MM | 1 |
Baxter, LR; Guzé, BH | 1 |
Addonizio, G; Susman, VL | 1 |
Van Haren, J; Vincent, FM; Zimmerman, JE | 1 |
Elderson, A; Verhoeven, WM | 1 |
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
Ciolino, C; Rosse, R | 1 |
Lucid, EJ; Martin, ML; Walker, RW | 1 |
Elderson, A; Verhoeven, WM; Westenberg, HG | 1 |
20 review(s) available for bromocriptine and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Diazepam; Dopamine D2 Receptor Antagonists; Electroconvulsive Therapy; Fluid Therapy; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Receptors, Dopamine D2; Reference Standards; Secondary Prevention | 2003 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors | 2007 |
[Drug-induced neuroleptic malignant syndrome].
Topics: Biomarkers; Bromocriptine; Creatine Kinase, MM Form; Cytochrome P-450 CYP2D6; Dantrolene; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Humans; Neuroleptic Malignant Syndrome; Polymorphism, Genetic; Psychotropic Drugs; Reference Standards; Risk Factors; Time Factors | 2007 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors | 1996 |
Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
Topics: Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Thioridazine | 1997 |
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders | 1999 |
Algorithms for the treatment of acute side effects induced by neuroleptics.
Topics: Algorithms; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Japan; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 1999 |
Clinical management of neuroleptic malignant syndrome.
Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty | 2001 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1990 |
Neuroleptic malignant syndrome: a report of a case and review of the literature.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Chronic Disease; Humans; Male; Neuroleptic Malignant Syndrome; Thailand | 1991 |
Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1991 |
Neuroleptic malignant syndrome.
Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis | 1989 |
Neuroleptic malignant syndrome: a review.
Topics: Bromocriptine; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Humans; Neuroleptic Malignant Syndrome; Recurrence; Risk Factors | 1989 |
Neuroleptic malignant syndrome.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Female; Humans; Male; Neuroleptic Malignant Syndrome; Receptors, Dopamine; Substance Withdrawal Syndrome | 1985 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrolene; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Female; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Receptors, Dopamine; Rhabdomyolysis; Schizophrenia | 1985 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats | 1986 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics | 1985 |
95 other study(ies) available for bromocriptine and Neuroleptic Malignant Syndrome
Article | Year |
---|---|
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrolene; Humans; Hydrocortisone; Male; Middle Aged; Neuroleptic Malignant Syndrome; Vaccination; Valproic Acid | 2022 |
Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation.
Topics: Antipsychotic Agents; Benzodiazepines; Bromocriptine; Creatine Kinase; Fever; Humans; Male; Neuroleptic Malignant Syndrome | 2022 |
Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report
Topics: Antipsychotic Agents; Bromocriptine; Chlorpyrifos; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Organophosphate Poisoning | 2022 |
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Flupenthixol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders | 2023 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia | 2020 |
Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dibenzocycloheptenes; Dopamine Agonists; Drug Overdose; Fluid Therapy; GABA Modulators; Heterocyclic Compounds, 4 or More Rings; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Valproic Acid | 2017 |
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Female; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Renal Dialysis; Treatment Outcome | 2019 |
[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine].
Topics: Antipsychotic Agents; Aripiprazole; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Frontotemporal Dementia; Humans; Imipramine; Lorazepam; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Inhalation Therapy; Piperazines; Quinolones; Respiration, Artificial; Respiratory Insufficiency | 2013 |
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Hydroxyzine; Infusions, Intravenous; Interdisciplinary Communication; Male; Neuroleptic Malignant Syndrome; Patient Care Team; Pharmaceutical Services; Treatment Outcome; Young Adult | 2016 |
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Chlorpromazine; Citalopram; Combined Modality Therapy; Dopamine Agonists; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Hypothermia, Induced; Infusions, Intravenous; Midazolam; Neuroleptic Malignant Syndrome; Olanzapine; Respiration, Artificial; Treatment Outcome | 2009 |
In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine".
Topics: Antipsychotic Agents; Benzodiazepines; Bromocriptine; Chlorpromazine; Disease Progression; Dopamine Agonists; Drug Overdose; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Serotonin Receptor Agonists; Treatment Outcome | 2009 |
The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine.
Topics: Bromocriptine; Dopamine Agonists; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 2010 |
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Data Interpretation, Statistical; Death; Female; Hormone Antagonists; Humans; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Risk Factors; Young Adult | 2010 |
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide.
Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide | 2002 |
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications | 2002 |
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment.
Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine | 2003 |
[Neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Respiratory Insufficiency | 2003 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome | 2004 |
Neuroleptic malignant syndrome after an emergency operation for acute appendicitis perforation.
Topics: Acute Disease; Anesthetics, General; Appendectomy; Appendicitis; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Treatment Outcome | 2004 |
Neuroleptic malignant syndrome with promethazine.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Neuroleptic Malignant Syndrome; Promethazine | 2005 |
Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever of Unknown Origin; Heat Stroke; Humans; Infections; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinsonian Disorders | 2005 |
Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
Topics: Aged; Antipsychotic Agents; Body Temperature; Bromocriptine; Cause of Death; Creatine Kinase; Dantrolene; Dopamine Agonists; Female; Humans; Japan; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Retrospective Studies; Risk Factors | 2005 |
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome | 2005 |
[A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
Topics: Bromocriptine; Cocaine; Dantrolene; Dopamine Agonists; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia; Treatment Outcome | 2006 |
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome | 2007 |
Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
Topics: Anemia, Hypochromic; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; beta-Thalassemia; Bipolar Disorder; Bromocriptine; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Hypothyroidism; Lithium Compounds; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia; Risperidone; Venous Thrombosis | 2007 |
Catatonia and neuroleptic malignant syndrome: two sides of a coin?
Topics: Adult; Aged; Alcoholism; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Bromocriptine; Catatonia; Dantrolene; Depression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychotic Disorders | 2007 |
Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Dantrolene; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 2008 |
[Association of an acute thyrotoxic crisis and the neuroleptic malignant syndrome. Efficacy of bromocriptine].
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Female; Humans; Neuroleptic Malignant Syndrome; Thyroid Crisis | 1984 |
[Acute renal failure in neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Renal Dialysis; Rhabdomyolysis | 1995 |
An atypical course of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors | 1994 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome and clozapine.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dantrolene; Diagnosis, Differential; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Schizophrenia | 1993 |
The neuroleptic malignant syndrome and acute renal failure.
Topics: Acute Kidney Injury; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Water-Electrolyte Imbalance | 1994 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome | 1993 |
[Malignant neuroleptic syndrome treated with bromocriptine].
Topics: Adult; Bromocriptine; Humans; Male; Neuroleptic Malignant Syndrome | 1993 |
[Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions].
Topics: Adult; Bromocriptine; Humans; Liver Diseases; Male; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome: case report in a multiple trauma patient.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Multiple Trauma; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome in a patient with head injury.
Topics: Adolescent; Bromocriptine; Craniocerebral Trauma; Creatine Kinase; Dantrolene; Hemofiltration; Humans; Male; Multiple Trauma; Neuroleptic Malignant Syndrome; Pancuronium; Rhabdomyolysis | 1996 |
Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Humans; Male; Neuroleptic Malignant Syndrome | 1996 |
[Malignant-like neuroleptic syndrome: a sign to call attention to].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease | 1995 |
[Neuroleptic malignant syndrome in the elderly: description of 4 patients].
Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Neuroleptic Malignant Syndrome | 1997 |
Neuroleptic malignant syndrome in a burn patient.
Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; Delirium; Dopamine Agonists; Fever; Follow-Up Studies; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Surgical Wound Infection | 1998 |
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus | 1999 |
Neuroleptic malignant syndrome in an adolescent head trauma patient.
Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral Trauma; Dantrolene; Female; Haloperidol; Humans; Motorcycles; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome | 1999 |
Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum.
Topics: Adrenergic Agents; Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Male; Neuroleptic Malignant Syndrome; Neurons; Oxidopamine; Piperazines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Substantia Nigra | 2000 |
Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Combined Modality Therapy; Cryotherapy; Dantrolene; Dopamine Agonists; Emergency Treatment; Hemiplegia; Humans; Intubation, Intratracheal; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2000 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2001 |
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema | 2002 |
Neuroleptic malignant syndrome in Malaysia: a university hospital experience.
Topics: Adolescent; Aged; Antipsychotic Agents; Bromocriptine; Female; Hospitals, University; Humans; Neuroleptic Malignant Syndrome; Retrospective Studies | 1992 |
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1992 |
Neuroleptic malignant syndrome and its successful treatment with bromocriptine--a case report.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1991 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia | 1991 |
Drug treatment of the neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome | 1991 |
Neuroleptic malignant syndrome (a case report).
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome | 1991 |
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
Topics: Adult; Bromocriptine; Combined Modality Therapy; Critical Care; Dantrolene; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Prospective Studies | 1991 |
Neuroleptic malignant syndrome improved by bromocriptine.
Topics: Bromocriptine; Humans; Neuroleptic Malignant Syndrome | 1991 |
A hazardous side effect of neuroleptics: diagnosis and treatment.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome | 1990 |
Bromocriptine and neuroleptic malignant syndrome.
Topics: Bromocriptine; Humans; Neuroleptic Malignant Syndrome | 1991 |
Positron emission tomographic studies of changes in cerebral blood flow and oxygen metabolism in neuroleptic malignant syndrome.
Topics: Adult; Blood Gas Analysis; Brain; Bromocriptine; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Consumption; Tomography, Emission-Computed | 1991 |
Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome?
Topics: Animals; Brain; Bromocriptine; Disease Models, Animal; Haloperidol; Halothane; Hyperthermia, Induced; Lithium; Lithium Carbonate; Neuroleptic Malignant Syndrome; Pilot Projects; Receptors, Dopamine; Swine; Swine Diseases | 1990 |
Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
Topics: Bromocriptine; Dantrolene; Desipramine; Dopamine; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Norepinephrine | 1990 |
[Protracted recurrent neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Recurrence | 1990 |
Neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndrome | 1990 |
[Neuroleptic malignant syndrome--life-threatening but treatable].
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Prognosis | 1990 |
Neuroleptic malignant syndrome improved by bromocriptine.
Topics: Adult; Bromocriptine; Humans; Isoniazid; Male; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced | 1990 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk | 1986 |
Neuroleptic malignant syndrome and psychotic illness.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Schizophrenia, Catatonic | 1989 |
Neuroleptic malignant syndrome with trifluperidol.
Topics: Adult; Bromocriptine; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Schizophrenic Psychology; Trifluperidol | 1989 |
Concomitant treatment of neuroleptic malignant syndrome and psychosis.
Topics: Adult; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Thioridazine | 1989 |
Neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Catatonia; Diagnosis, Differential; Female; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome | 1985 |
Diagnosing and treating neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Creatine Kinase; Dantrolene; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Terminology as Topic | 1986 |
Rigidity and fever in two psychotic patients.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1986 |
Therapeutic rounds: neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Catatonia; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary | 1986 |
Neuroleptic malignant syndrome superimposed on tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Male; Neuroleptic Malignant Syndrome | 1987 |
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Receptors, Dopamine; Schizophrenia | 1988 |
Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome | 1988 |
Neuroleptic malignant syndrome.
Topics: Adult; Aged; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Family Practice; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Pneumococcal | 1988 |
Diagnosis and treatment of neuroleptic malignant syndrome.
Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome | 1988 |
Emergency treatment of the neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Clinical Protocols; Dantrolene; Emergencies; Humans; Male; Neuroleptic Malignant Syndrome | 1988 |
Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs.
Topics: Adult; Benztropine; Bromocriptine; Drug Therapy, Combination; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Tropanes | 1988 |
Neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Female; Humans; India; Male; Neuroleptic Malignant Syndrome | 1987 |
The neuroleptic malignant syndrome after open heart surgery: successful treatment with bromocriptine.
Topics: Aged; Bromocriptine; Coronary Artery Bypass; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications | 1987 |
Navigating neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1986 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Successful treatment of neuroleptic malignant syndrome with bromocriptine.
Topics: Administration, Oral; Aged; Body Temperature; Bromocriptine; Creatine Kinase; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome | 1986 |
Bromocriptine treatment of neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Bromocriptine; Creatine Kinase; Drug Evaluation; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Time Factors | 1987 |
Assessing treatment of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Cortisone; Drug Therapy, Combination; Humans; Neuroleptic Malignant Syndrome; Piperidines | 1986 |
Neuroleptic malignant syndrome complicating closed head injury.
Topics: Adult; Brain Injuries; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Wounds, Nonpenetrating | 1986 |
[Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine].
Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome | 1985 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1985 |
Neuroleptic malignant syndrome: successful treatment with bromocriptine.
Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Creatine Kinase; Haloperidol; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome; Paranoid Disorders; Prolactin; Transaminases | 1985 |